The Plain Record

Neutral daily news — clear headlines, complete facts.

Business

Applied Nutrition profits rise 43.9% amid demand for weight-loss support products

Applied Nutrition reported a 43.9% rise in annual pre-tax profits to £41 million, driven by demand for whey protein and products for weight-loss medication users.

Published November 16, 2026 at 3:23 AM EST

The short answer

Applied Nutrition reported a 43.9% rise in annual pre-tax profits to £41 million, driven by demand for whey protein and products for weight-loss medication users.

Applied Nutrition profits rise 43.9% amid demand for weight-loss support products

The Facts

Who
Applied Nutrition, CEO Thomas Ryder, and partner Coleen Rooney.
What
Annual financial results reporting profit and sales growth.
When
Monday, November 16, 2026
Where
Liverpool, United Kingdom and global markets.
Why
The company saw increased demand for whey protein and launched a range for users of weight-loss medication.

Applied Nutrition reported a 43.9% increase in pre-tax profits for the fiscal year ending July 31, 2026, reaching £41 million. The company, which is listed on the London Stock Exchange and backed by TV personality Coleen Rooney, saw its total sales grow by 50.9% to £161.6 million during the same period.

The growth was driven by high demand for whey-based products and the launch of the "GLP-1 Friendly Range." This product line is marketed to individuals using weight-loss medications, such as GLP-1 agonists. Sales of the company's "Critical Whey" product increased by 142% over the 2025-26 financial year following a relaunch.

Chief Executive Thomas Ryder stated that the company is focusing on innovation to reach consumers who may not have previously purchased sports nutrition products. The Liverpool-based firm distributes to more than 80 countries, selling primarily to retailers, gyms, grocers, and sports clubs. The company noted that its partnership with Coleen Rooney has helped expand its customer base beyond traditional athletes.

Despite the rise in revenue, the company noted that high raw material costs for whey protein would affect profitability. While the firm said the price of whey protein has recently begun to decrease, it has implemented price increases to offset previous cost spikes. For the 2026-27 financial year, the board maintained its current guidance, forecasting underlying earnings of approximately £49 million and sales of about £205 million.

A specific group affected by these developments is the population of people using weight-loss medications. These individuals are the target of the new GLP-1 Friendly Range. The 142% surge in Critical Whey sales indicates consumer demand for protein-heavy products, which may influence how retailers and gyms stock their shelves.

The company’s focus on the weight-loss medication market reflects how the health and wellness industry reacts to pharmaceutical trends. What happens next depends on market volatility; the company will monitor whey protein costs and consumer demand through the 2026-27 fiscal year toward the targeted £205 million sales goal.

Timeline of what happened

Key dates and decisions, in the order they occurred.

  1. July 31, 2026

    End of fiscal year reporting period

  2. November 16, 2026

    Annual financial results released to the public

Summaries are written by The Plain Record to state the facts of a story plainly and without political slant. Drafted with AI assistance and checked against the source record before publication. See how we report, or report a correction.

← Back to the front page

Questions readers ask

What happened: Applied Nutrition profits rise 43.9% amid demand for weight-loss support products?

Applied Nutrition reported a 43.9% increase in pre-tax profits for the fiscal year ending July 31, 2026, reaching £41 million. The company, which is listed on the London Stock Exchange and backed by TV personality Coleen Rooney, saw its total sales grow by 50.9% to £161.6 million during the same period.

Who is involved?

Applied Nutrition, CEO Thomas Ryder, and partner Coleen Rooney.

When did this happen?

Monday, November 16, 2026

Where did this happen?

Liverpool, United Kingdom and global markets.

Why does this matter?

The company saw increased demand for whey protein and launched a range for users of weight-loss medication.